Tyro Capital Management LLC: ARS PHARMACEUTICALS INC (SPRY): Quarterly 13F Position History
As of Q1 2026, Tyro Capital Management LLC reported 2,968,599 shares of ARS PHARMACEUTICALS INC (SPRY), worth $23.8M and representing 6.0% of its 13F equity book. Quarter-over-quarter share count change: + 973,747 (+48.8%) . The position first appeared in Q4 2025 and has been disclosed across 2 13F-HR filings in Pactolio's tracked window.
- 2,968,599Shares Held (Latest Filing)
- $23.8MReported Market Value (Latest Filing)
- 6.0%Portfolio Weight (% of 13F Equity Book)
- +973,747Quarter-over-Quarter Share Change
- +$597.8KQuarter-over-Quarter Value Change
- 2,968,599Peak Reported Shares (Historical)
Recent initiation: Tyro Capital Management LLC first reported SPRY on the Q4 2025 filing — fewer than three quarters of history are available.
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 2 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 2,968,599 | +973,747 | +48.8% | $23.8M | 6.0% | $8.0 |
| Q4 2025 | 1,994,852 | — | — | $23.2M | 6.8% | $11.7 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Tyro Capital Management LLC first disclose a SPRY position in 13F-HR filings?
Tyro Capital Management LLC first reported ARS PHARMACEUTICALS INC (SPRY) on its 13F-HR filing for the period ending 2025-12-31 (Q4 2025). The position has appeared on 2 reported quarters within Pactolio's tracked window.
What was Tyro Capital Management LLC's most recent quarter-over-quarter share-count change in SPRY?
Between Q4 2025 and Q1 2026, Tyro Capital Management LLC added 973,747 shares of SPRY (+48.8%), bringing the total reported position to 2,968,599 shares at a market value of $23.8M.
Does the implied price-per-share represent Tyro Capital Management LLC's cost basis in SPRY?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.